Browse drugs

…y improved insulin sensitivity (SI=2.75±0.37 pM⁻¹·min⁻¹), while semaglutide and sham produced only modest effects. These findings support c…

…ufactured GLP-1RA products (active ingredients: liraglutide and semaglutide) in people with type 2 diabetes and/or overweight/obesity. Pote…

…diovascular risk and limiting access to kidney transplantation. Semaglutide, a glucagon-like peptide-1 receptor agonist, improves glycaemic…

…particularly relevant for GLP-1 receptor agonists. For example, semaglutide has demonstrated dose-dependent effects on glycemic control and…

…ical analysis showed that the vial contained insulin instead of semaglutide, therefore leading to severe hypoglycaemia. This case highlight…

…An older woman with dementia and type 2 diabetes was started on semaglutide and subsequently developed severe psychological and physical sy…

… treatments. Glucagon-like peptide-1 receptor agonists, such as semaglutide, have shown promise in modulating reward-related behaviours and…

…e age, duration of T2D, sex, BMI (<30, ≥30 and <35, ≥35 kg/m2), dulaglutide dose, and duration of dulaglutide treatment. The tirzepatide tr…

…Semaglutide, marketed as Ozempic, Wegovy and Rybelsus, has rapidly become o…

…se in patients with cardiovascular disease and type 2 diabetes. Semaglutide, tirzepatide and liraglutide are approved by the US Food and Dr…

…x (BMI): 51.1 kg/m 2) had been treated with a weekly 0.25 mg of semaglutide injection for DM by a physician in another hospital. She was of…

…t loss, lifestyle changes and semaglutide treatment. To receive semaglutide treatment, patients were required to participate in GCs focused…